Loading the content... Loading depends on your connection speed!

Enter New Email
Confirm New Email
Enter Old Password
Enter New Password
Confirm New Password
 
Email sent successfully to:
Evaluation
 

Predicting Cycle One Serious Drug-Related Toxicity (SDRT) in Phase I Oncology Trial
Processing...

MyLikes

MyPaths

Info
U/L
mL/min
Algorithm Information

Predicting Cycle One Serious Drug-Related Toxicity (SDRT) in Phase I Oncology Trial

MyLikes

MyPaths
Purpose:
To identify a patient undergoing a Phase I oncology trial at risk for a serious drug-related toxicity (SDRT) based on the study of Hyman et al.
Specialty
  • Hematology Oncology
Objective
  • Dosage calculations
  • Adverse effects
  • Drug levels
  • Overdose and reversal
ICD-10
  • T45.1
  • Y43.3
References
Interpretation and Description
Share this Algorithm
MyPaths
Cancel
Create Path
Create
Cancel
Create Note
Save
Predicting Cycle One Serious Drug-Related Toxicity (SDRT) in Phase I Oncology Trial
Cancel
Save Data
Save
Limitation to 5 characters is for patient privacy.